XML 102 R87.htm IDEA: XBRL DOCUMENT v3.22.2
Convertible Notes Receivable - Additional Information (Details)
$ / shares in Units, $ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
Apr. 10, 2019
CAD ($)
shares
Dec. 28, 2018
CAD ($)
$ / shares
Sep. 30, 2021
USD ($)
shares
Aug. 31, 2021
CAD ($)
shares
May 31, 2022
USD ($)
shares
May 31, 2021
USD ($)
May 31, 2021
CAD ($)
May 31, 2020
USD ($)
May 31, 2021
CAD ($)
Apr. 11, 2021
CAD ($)
Apr. 10, 2021
CAD ($)
Convertible Notes Receivable [Line Items]                      
Unrealized loss on convertible notes receivable         $ (71,428) $ (3,824)   $ (5,476)      
Secured Convertible Debentures | High Tide Inc                      
Convertible Notes Receivable [Line Items]                      
Debt instrument, face amount                   $ 2,000 $ 2,500
Secured Convertible Debentures | Aphria Inc | Starbuds                      
Convertible Notes Receivable [Line Items]                      
Debentures purchased   $ 5,000                  
Debt instrument interest rate percentage   8.50%                  
Debt instrument maturity date   Dec. 28, 2020                  
Debt instrument conversion price per share | $ / shares   $ 0.50                  
Fair value of convertible debentures           828     $ 1,000    
Accrued Interest           385 $ 465        
Secured Convertible Debentures | Aphria Inc | High Tide Inc                      
Convertible Notes Receivable [Line Items]                      
Debentures purchased $ 4,500                    
Debt instrument interest rate percentage 10.00%                    
Debt instrument maturity date Apr. 10, 2021                    
Debt instrument frequency of periodic payment         annually            
Warrants received | shares 6,000,000                    
LP                      
Convertible Notes Receivable [Line Items]                      
Ownership and voting interest         68.00%            
Convertible Notes Receivable                      
Convertible Notes Receivable [Line Items]                      
Proceeds from issuance of debt         $ 948            
Convertible Notes Receivable | Risk-Free Interest Rate                      
Convertible Notes Receivable [Line Items]                      
Debt instrument measurement input         0.0143            
Convertible Notes Receivable | Expected Volatility                      
Convertible Notes Receivable [Line Items]                      
Debt instrument measurement input         0.70            
Convertible Notes Receivable | Minimum | Probability of Legalization                      
Convertible Notes Receivable [Line Items]                      
Debt instrument measurement input         0            
Convertible Notes Receivable | Maximum | Probability of Legalization                      
Convertible Notes Receivable [Line Items]                      
Debt instrument measurement input         60            
MedMen Enterprises Inc. | Convertible Notes Receivable                      
Convertible Notes Receivable [Line Items]                      
Debt instrument, face amount         $ 165,799            
Unrealized loss on convertible notes receivable         $ 71,428 $ 3,824          
LP                      
Convertible Notes Receivable [Line Items]                      
Shares issued for acquisition, shares | shares     9,817,061   9,817,061            
Shares issued for acquisition     $ 117,804   $ 117,804            
Ownership and voting interest     68.00% 68.00% 68.00%            
Common stock issued, shares | shares       9,817,061              
LP | Secured Convertible Debentures | MedMen Enterprises Inc.                      
Convertible Notes Receivable [Line Items]                      
Debt instrument, face amount       $ 165,799              
Debt instrument maturity date       Aug. 17, 2028              
LP | Secured Convertible Debentures | MedMen Enterprises Inc. | LIBOR                      
Convertible Notes Receivable [Line Items]                      
Interest rate       6.00%              
LP | Secured Convertible Debentures | MedMen Enterprises Inc. | LIBOR | Floor                      
Convertible Notes Receivable [Line Items]                      
Interest rate       2.50%              
LP | LP                      
Convertible Notes Receivable [Line Items]                      
Non-controlling interest percentage         32.00%